×
About 805 results

ALLMedicine™ Eye Disorders Center

Research & Reviews  192 results

Natural History, Pathogenesis, and Outcome of Ocular Disorders
https://clinicaltrials.gov/ct2/show/NCT02821767

Jul 25th, 2022 - The National Eye Institute (NEI) is conducting a study to evaluate and provide standard treatment to participants with various diagnosed and undiagnosed ocular conditions. Objective: The primary objective of this protocol is to provide short term ...

Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice
https://clinicaltrials.gov/ct2/show/NCT04137120

Jul 25th, 2022 - The primary objective is to assess the safety of intravitreal aflibercept injections in patients with wet age-related macular degeneration (wAMD), myopic choroidal neovascularization (mCNV), diabetic macular edema (DME), macular edema secondary to...

The association between the use of sodium glucose cotransporter 2 inhibitor and the ris...
https://doi.org/10.1080/17512433.2022.2102973
Expert Review of Clinical Pharmacology; Ma Y, Lin C et. al.

Jul 16th, 2022 - To assess the association between the use of sodium-glucose cotransporter 2 inhibitor (SGLT2i) and the incidence of diabetic retinopathy (DR). PubMed, Medline, Embase, the Cochrane Central Register of Controlled Trials, and Clinicaltrial.gov were ...

Analysis of adverse drug events in pulmonary Mycobacterium avium complex disease using ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241207
BMC Infectious Diseases; Ozawa T, Namkoong H et. al.

Jun 30th, 2022 - In Japan, Mycobacterium avium complex lung disease (MAC-LD) is the most common in nontuberculous mycobacterial lung disease. Patients often experience adverse events, resulting in the discontinuation of treatment, which causes treatment failure. T...

Ophthalmologic and facial abnormalities of Nicolaides-Baraitser syndrome.
https://doi.org/10.1080/13816810.2022.2089358
Ophthalmic Genetics; Simmers R, Goodwin A et. al.

Jun 29th, 2022 - Nicolaides-Baraitser syndrome (NCBRS), first described in 1993, is a rare autosomal dominant disease caused by pathogenic variants in the SMARCA2 gene on chromosome 9p24.3. NCBRS typically presents with dysmorphic facial features, seizures, intell...

see more →

Drugs  70 results see all →

Clinicaltrials.gov  10 results

Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice
https://clinicaltrials.gov/ct2/show/NCT04137120

Jul 25th, 2022 - The primary objective is to assess the safety of intravitreal aflibercept injections in patients with wet age-related macular degeneration (wAMD), myopic choroidal neovascularization (mCNV), diabetic macular edema (DME), macular edema secondary to...

Natural History, Pathogenesis, and Outcome of Ocular Disorders
https://clinicaltrials.gov/ct2/show/NCT02821767

Jul 25th, 2022 - The National Eye Institute (NEI) is conducting a study to evaluate and provide standard treatment to participants with various diagnosed and undiagnosed ocular conditions. Objective: The primary objective of this protocol is to provide short term ...

Feasibility of Estimating the Prevalence of Malnutrition, Frailty and Sarcopenia in Older People in UK Biobank, Cross-sectional Study: A Study Protocol
https://clinicaltrials.gov/ct2/show/NCT04655456

Apr 30th, 2021 - The UK Biobank is a population-based study of a large prospective longitudinal cohort with information on 500,000 people, who were aged 40-69 when recruited in 2006-2010 from England, Scotland and Wales. The database includes demographic data, onl...

Evaluation and Treatment of People With Eye Diseases
https://clinicaltrials.gov/ct2/show/NCT00708955

Dec 16th, 2019 - The National Eye Institute (NEI) is conducting a study to evaluate and provide standard treatment to participants with various diagnosed and undiagnosed ocular conditions. Objectives: The primary objective of this protocol is to provide a reservoi...

Epidemiologic Survey to Describe the Current Medical Practice of General Practitioners Treating Subjects With Type 2 Diabetes Mellitus in Latina
https://clinicaltrials.gov/ct2/show/NCT01387165

Jun 8th, 2017 - The DEAL (Diabetes En America Latina) study was a multicenter, cross-sectional, epidemiological, questionnaire based study carried out between October 2004 and October 2005 in 9 Latin American countries. General practitioners (GP) from private set...

see more →

News  45 results

How Can the US Improve Access to Eyeglasses?
https://www.medscape.com/viewarticle/974468

May 23rd, 2022 - Many Americans do not have access to a simple but life-changing device: eyeglasses. In a 2017 survey, nearly 1 in 10 Americans who reported needing glasses said they could not afford them. More than 2 million children in the United States also do ...

Study Confirms Link Between Dementia Risk and Eye Disorders
https://www.medscape.com/viewarticle/960267

Oct 6th, 2021 - NEW YORK (Reuters Health) - A heightened risk of all-cause dementia was found to be associated with age-related macular degeneration (AMD), cataract and diabetes-related eye disease (DRED), but not glaucoma, according to data from the UK Biobank. ...

Maternal Diabetes in Pregnancy Linked to High Refractive Error in Children's Eyes
https://www.medscape.com/viewarticle/956982

Aug 24th, 2021 - (Reuters Health) - Children of mothers who have diabetes before or during pregnancy are more likely to develop high refractive error eye disorders later in life, a new study suggests. An analysis of data from more than 20,000 children in Denmark f...

Allergic Conjunctivitis Severely Affects Children's Quality of Life
https://www.medscape.com/viewarticle/953091

Jun 15th, 2021 - Allergic conjunctivitis harms quality of life for children and their parents, apparently causing greater day-to-day worries than potentially blinding diseases, researchers report. Parents worry especially that treatments might not be effective, ac...

Novel Targeted Antibody-Drug Conjugates in Non-Hodgkin Lymphoma
https://www.onclive.com/view/novel-targeted-antibodydrug-conjugates-in-nonhodgkin-lymphoma

Dec 5th, 2020 - Overview of Non-Hodgkin Lymphoma Antibody-drug conjugates (ADCs) represent a targeted class of agents with an improved therapeutic index over traditional chemotherapy in the treatment of non-Hodgkin lymphoma (NHL). Despite the potential of these ...

see more →

Patient Education  5 results see all →